PepGen Inc. (BOATS:PEPG) Financings

PepGen Inc.

Financings

RaiseDate
Public offering of common stock
Update: US$125M · US$5 a share · Leerink Partners +4
Dealers: Leerink Partners (co-lead), Stifel (co-lead), Guggenheim Securities (co-lead), Oppenheimer & Co., H.C. Wainwright & Co.
Use of proceeds: Fund ongoing clinical development of its product candidate, working capital and general corporate purposes
Nov 12, 2026
Public offering of common stock
Closed: US$115M raised · US$3.2 a share · Leerink Partners +1
Dealers: Leerink Partners (co-lead), Stifel (co-lead)
Use of proceeds: Research and clinical development, including the FREEDOM-DM1 and FREEDOM2-DM1 trials, working capital and general corporate purposes
Sep 29, 2025

Read by 6ix AI from the company's releases